IncellDx to study Maraviroc, a CCR5 antagonist, in a COVID-19 phase 2 clinical trial ... Oct 20
The future will be shaped by societies that invest in science and innovation - PM Modi... Oct 20
Orgenesis Completes acquisition of Koligo Therapeutics and announces additional acquisition of Icellator technology from tissue genesis in related transaction ... Oct 20
These submissions are an important step forward in the commitment to providing an additional treatment option ... Oct 20
Ezra's Prostate AI is the first to ever be cleared by the FDA for prostate and lesion segmentation using AI ... Oct 20
-Advertisements-